HealthCare Institute of New Jersey Statement on US-UK Agreement on Drug Pricing
Trenton, December 1, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning today’s